This was further confirmed by the finding that genes such as TAGLN and TPM2 were downregulated in CAF-S5 in early NSCLC, as they would contribute to contractility also, and that contractile pathways were suppressed (Fig. S5). The gene discussed is TPM2; the disease is non-small cell lung carcinoma.